Neuralgia Treatment Market

Neuralgia Treatment Market by Treatment (Drug-based {Anticonvulsant Medicines, and Tricyclic Antidepressants} and Surgery {Balloon Compression, Glycerol Injection, Microvascular Decompression, Radiofrequency Thermal Lesioning, and Stereotactic Radiosurgery}), Indications (Diabetic Neuralgia, Intercostal Neuralgia, Occipital Neuralgia, Peripheral Neuralgia, Postherpetic Neuralgia, and Trigeminal Neuralgia), Applications (Hospital, Clinics, and Others), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa)- Global Industry Analysis, Growth, Share, Size, Trends, and Forecast, 2021-2028

  • Report ID: HC-450
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 3
  • No. Of Pages: 154
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global neuralgia treatment market was valued at USD 1.8 billion in 2019 and is expanding at a CAGR of 6.0% during the forecast period, 2021-2028. The growth of the market is attributed to increasing number of diabetic patients and high rate of trigeminal neuralgia. Furthermore, conditions such as multiple sclerosis can cause neuralgia. Multiple sclerosis is a condition in which the body’s immune system attacks the myelin sheath, which in turn, causes neuralgia.

Neuralgia is a short, recurring pain in body parts or along a specific nerve. The sensation of pain may feel like stabbing, burning, or an electric shock. The condition is caused, due to the damage to the peripheral nervous system, beyond the brain, and is known as peripheral neuralgia.

Global Neuralgia Treatment Market Summary

Market Trends, Drivers, Restraints, and Opportunities:

  • Increasing number of patients with trigeminal neuralgia is driving the neuralgia treatment market.
  • Rising geriatric population across the world propels the neuralgia treatment market.
  • Increasing number of diabetic patients is anticipated to drive the market.
  • High costs imposed on surgery is hampering the market growth.
  • People belonging to low-income groups cannot afford the neuralgia treatment, as it is expensive. This factor is restraining the market growth.
  • Adverse effects related to the neuralgia treatment and presence of alternative therapies may hamper the neural pain treatment market.
  • Technological advancement leads to new opportunities in the neuralgia treatment market.

Scope of the report:

The report on acupuncture needles market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have been included in the report.

Attributes

Details

Report Title

Neuralgia Treatment Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018-2019

Forecast Period

2021-2028

Segmentation

Treatment (Drug-based {Anticonvulsant Medicines, and Tricyclic Antidepressants} and Surgery {Balloon Compression, Glycerol Injection, Microvascular Decompression, Radiofrequency Thermal Lesioning, and Stereotactic Radiosurgery}), Indications (Diabetic Neuralgia, Intercostal Neuralgia, Occipital Neuralgia, Peripheral Neuralgia, Postherpetic Neuralgia, and Trigeminal Neuralgia), Applications (Hospital, Clinics, and Others)

Regional Scope

Asia Pacific, North America, Europe, Latin America, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players

GlaxoSmithKline PLC, Pfizer Inc., Novartis AG, Biogen, Cadila Healthcare Limited, Lundbeck Pharmaceuticals LLC, Allergan Plc, GlaxoSmithKline Plc., Biogen Inc. and Abbott Laboratories

 

Neuralgia Treatment Market Segment Insights:

Global Neuralgia Treatment Market Taxonomy

Surgery-based Treatment Market held a significant market share
Based on treatment, the neuralgia treatment market is fragmented into drug-based and surgery. The surgery-based treatment segment held the maximum market share in 2019 and is anticipated to grow significantly during the forecast period. The segment is driven by increasing awareness about various treatment options and high cost of surgeries. The surgery segment is sub-segmented into radiofrequency thermal lesioning, stereotactic radiosurgery, Microvascular Decompression (MVD), and others. MVD held a key market share in 2019.

Hospitals and Clinics segment held a key market share in 2019
On the basis of distribution channels, the neuralgia treatment market can be fragmented into hospitals, clinics, retail, and others. The hospitals and clinics segment is expected to dominate the neuralgia treatment market and hold a key revenue share during the forecast period. Increasing cases of neuralgia and rising number of surgical procedures are driving the market. As per the National Institute of Neurological Disorders and Stroke, trigeminal neuralgia is a progressive disorder and often becomes resistant to medication. Hence, the patients usually opt for surgeries.

The ambulatory surgery centers segment is expected to grow rapidly during the forecast period. The growth of the segment is attributed to increasing demand for a reduction in hospital stay. Treatment procedures such as radiofrequency rhizotomy are performed under general anesthesia. This procedure takes a few minutes in the operating room and few additional hours in the recovery room.

North-America dominates the global market
In terms of regions, the neuralgia treatment market is expected to grow rapidly during the forecast period. North America dominated the market and accounted for a revenue share in 2019. The market in North America is anticipated to grow rapidly during the forecast period. Availability of urinary drainage bags market in North America is driven by rising incidence of neuralgia and the presence of key market players in the region. Furthermore, increasing awareness regarding different treatment options is expected to boost the market in North America.

The market in Asia Pacific is anticipated to grow rapidly during the forecast period. The market growth is attributed to rising incidence of diabetes and growing geriatric population in the region. For instance, the prevalence rate of diabetes in adults in India is 8.9%. Such a high prevalence rate of diabetes is expected to grow the market for neuralgia treatment.

Global Neuralgia Treatment Market By Region

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Neuralgia Treatment Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Neuralgia Treatment Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Neuralgia Treatment Market - Supply Chain
  4.5. Global Neuralgia Treatment Market Forecast
     4.5.1. Neuralgia Treatment Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Neuralgia Treatment Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Neuralgia Treatment Market Absolute $ Opportunity
5. Global Neuralgia Treatment Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Neuralgia Treatment Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Neuralgia Treatment Demand Share Forecast, 2019-2026
6. North America Neuralgia Treatment Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Neuralgia Treatment Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Neuralgia Treatment Demand Share Forecast, 2019-2026
7. Latin America Neuralgia Treatment Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Neuralgia Treatment Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Neuralgia Treatment Demand Share Forecast, 2019-2026
8. Europe Neuralgia Treatment Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Neuralgia Treatment Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Neuralgia Treatment Demand Share Forecast, 2019-2026
9. Asia Pacific Neuralgia Treatment Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Neuralgia Treatment Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Neuralgia Treatment Demand Share Forecast, 2019-2026
10. Middle East & Africa Neuralgia Treatment Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Neuralgia Treatment Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Neuralgia Treatment Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Neuralgia Treatment Market: Market Share Analysis
  11.2. Neuralgia Treatment Distributors and Customers
  11.3. Neuralgia Treatment Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. GlaxoSmithKline PLC
     11.4.2. Pfizer Inc.
     11.4.3. Novartis AG
     11.4.4. Biogen
     11.4.5. Cadila Healthcare Limited
     11.4.6. Lundbeck Pharmaceuticals LLC
     11.4.7. Allergan Plc
     11.4.8. GlaxoSmithKline Plc
     11.4.9. Biogen Inc.
     11.4.10. Abbott Laboratories
Segments Covered in the Report:
By Treatment
  • Drug-based
    • Anticonvulsant Medicines
    • Tricyclic Antidepressants
  • Surgery
    • Balloon Compression
    • Glycerol Injection
    • Radiofrequency Thermal Lesioning
    • Stereotactic Radiosurgery
    • Microvascular Decompression
    • Others
By Indication
  • Diabetic Neuropathy
  • Intercostal Neuralgia
  • Occipital Neuralgia
  • Peripheral Neuralgia
  • Postherpetic Neuralgia
  • Trigeminal Neuralgia
By Distribution Channel
  • Drug Stores
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Key Players
  • GlaxoSmithKline PLC
  • Pfizer Inc.
  • Novartis AG
  • Biogen
  • Cadila Healthcare Limited
  • Lundbeck Pharmaceuticals LLC
  • Allergan Plc
  • GlaxoSmithKline Plc
  • Biogen Inc.
  • Abbott Laboratories

Key players in the neuralgia treatment market include GlaxoSmithKline PLC, Pfizer Inc., Novartis AG, Biogen, Cadila Healthcare Limited, Lundbeck Pharmaceuticals LLC, Allergan Plc, GlaxoSmithKline Plc., Biogen Inc. and Abbott Laboratories. For instance, in February 2019, Zydus Cadila received FDA approval to market Carbamazepine, which is used in treatment of neuralgia.

Global Neuralgia Treatment Market By Key Players

Buy Report